AI-assisted, human-published
05/06/2025 /Funding Events
NewLimit Secures $130M Series B to Develop Anti-Aging Medicine
Biotech startup NewLimit raises $130 million to advance research in anti-aging medicine and cell reprogramming, while utilizing AI for drug development.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com